Issue Date | Title | Author(s) |
Dec-2022 | Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China | Liu, Weiping; Ji, Jie; Zou, Dehui; Cao, Yang; Xu, Yajing; Zhou, Jian; Gao, Sujun; Wang, Fengrong; Chen, Wenming; Du, Juan; Zhou, Hui; Zhou, Fuling; Shi, Jimin; Zhang, Xi; Yang, Jianmin; Jing, Hongmei; Jiang, Zhongxing; Liu, Hui; Li, Caixia; Peng, Hongling; Jiang, Songfu; Wei, Xiaolei; He, Pengcheng; Liu, Yao; Yang, Haiyan; Li, Zengjun; Huang, Xiaobing; Liu, Lin; Shen, Lijing; Liu, Chuanfang; Song, Yuqin; Qiu, Lugui; Wang, Xiaopei; Ma, Jun; Zhu, Jun |
2017 | Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China | Shi, Yuankai; Jia, Bo; Xu, Wei; Li, Wenyu; Liu, Ting; Liu, Peng; Zhao, Weili; Zhang, Huilai; Sun, Xiuhua; Yang, Haiyan; Zhang, Xi; Jin, Jie; Jin, Zhengming; Li, Zhiming; Qiu, Lugui; Dong, Mei; Huang, Xiaobing; Luo, Yi; Wang, Xiaodong; Wang, Xin; Wu, Jianqiu; Xu, Jingyan; Yi, Pingyong; Zhou, Jianfeng; He, Hongming; Liu, Lin; Shen, Jianzhen; Tang, Xiaoqiong; Wang, Jinghua; Yang, Jianmin; Zeng, Qingshu; Zhang, Zhihui; Cai, Zhen; Chen, Xiequn; Ding, Kaiyang; Hou, Ming; Huang, Huiqiang; Li, Xiaoling; Liang, Rong; Liu, Qifa; Song, Yuqin; Su, Hang; Gao, Y |
4-Nov-2021 | A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China | Liu, Weiping; Zhao, Donglu; Liu, Ting; Niu, Ting; Song, Yongping; Xu, Wei; Jin, Jie; Cai, Qingqing; Huang, Huiqiang; Li, Zhiming; Hou, Ming; Zhang, Huilai; Zhou, Jianfeng; Hu, Jianda; Shen, Jianzhen; Shi, Yuankai; Yang, Yu; Zhang, Liling; Zhao, Weili; Ding, Kaiyang; Qiu, Lugui; Tan, Huo; Zhang, Zhihui; Liu, Lihong; Wang, Jinghua; Xu, Bing; Zhou, Hui; Gao, Guangxun; Xue, Hongwei; Bai, Ou; Feng, Ru; Huang, Xiaobing; Yang, Haiyan; Yan, Xiaojing; Zeng, Qingshu; Liu, Peng; Li, Wenyu; Mao, Min; Su, Hang; Wang, Xin; Xu, Jingyan; Zhou, Daobin; Zhang, Hongyu; Ma, Jun; Shen, Zhixiang; Zhu, Jun |
2-Nov-2023 | Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter Study | Zhou, Jianying; Wang, Song; Niu, Ting; Jiang, Ming; Wang, Shunqing; Wang, Wen; Zhang, Xi; Dong, Yujun; Wan, Dingming; Du, Xin; Wei, Xudong; Zhu, Han; Li, Yuhua; Bi, Kehong; Song, Xianmin; Chen, Yi; Liu, Li; Luo, Yi; Zhou, Yuhong; Li, Xin; Xu, Yajing; Zhang, Yicheng; Liu, Xiaoliang; Yi, Hai; Huang, Xiaobing; Zhu, Zunmin; Yang, Jianmin; Zhou, Fang; Zhang, Xiaohui |
2008 | Synthesis of carbon nanotube using MnCl2 as catalytic precursors by CVD | Huang, Xiaobing; Gao, Hong; Wei, Dapeng; Chen, Qing |
5-Nov-2024 | Weekly Selinexor, Bortizomib and Dexamethasone (SVd) Versus Twice Weekly Bortizomib and Dexamethasone (Vd) in Chinese Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Primary Analysis of Phase 3 Bench Study | Lu, Jin; Geng, Liangquan; Chen, Lijuan; Liu, Peng; Zhong, Yuping; Liu, Zhuogang; Xia, Zhongjun; Mi, Jianqing; Li, Chunrui; Zhang, Xi; He, Yanjuan; Wei, Yongqiang; Fang, Baijun; Li, Fei; Cai, Zhen; Wang, Yafei; Huang, Dongping; Liu, Hong; Hou, Ming; Fu, Rong; Du, Xin; Fang, Xiaosheng; Zeng, Qingshu; Gao, Wen; Wang, Wei; Chang, Chunkang; Ouyang, Guifang; Liu, Jing; Weng, Jianyu; Huang, Xiaobing; Yu, Yang; Guo, Zhi; Zhao, Jun; Hou, Jian |